CDK9 and cancer: These results indicate that inhibition of CDK9 might be reducing cell viability by elevating p53 levels while simultaneously suppressing the levels of Mcl1 and the embryonic stem-cell transcription factors Sox2 and Sox9, which are known to promote cancer cell survival.